Venner P - Search Results

1

Associations between exercise and quality of life in bladder cancer survivors: a population-based study.

Karvinen KH, Courneya KS, North S, Venner P. Karvinen KH, et al. Among authors: venner p. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):984-90. doi: 10.1158/1055-9965.EPI-06-0680. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17507626

2

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.

Scrimger RA, Murtha AD, Parliament MB, Venner PM, Hanson J, Houle G, Chetner M. Scrimger RA, et al. Among authors: venner pm. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):23-30. doi: 10.1016/s0360-3016(01)01591-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11516847

3

Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.

Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA. Segal RJ, et al. J Clin Oncol. 2003 May 1;21(9):1653-9. doi: 10.1200/JCO.2003.09.534. J Clin Oncol. 2003. PMID: 12721238 Clinical Trial.

4

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

Jurasz P, North S, Venner P, Radomski MW. Jurasz P, et al. Among authors: venner p. Thromb Res. 2003;112(1-2):59-64. doi: 10.1016/j.thromres.2003.10.012. Thromb Res. 2003. PMID: 15013275 Clinical Trial. No abstract available.

5

Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors.

Courneya KS, Segal RJ, Reid RD, Jones LW, Malone SC, Venner PM, Parliament MB, Scott CG, Quinney HA, Wells GA. Courneya KS, et al. J Clin Epidemiol. 2004 Jun;57(6):571-9. doi: 10.1016/j.jclinepi.2003.11.010. J Clin Epidemiol. 2004. PMID: 15246125 Clinical Trial.

6

A pilot study of the liposomal MUC1 vaccine BLP25 in prostate specific antigen failures after radical prostatectomy.

North SA, Graham K, Bodnar D, Venner P. North SA, et al. Among authors: venner p. J Urol. 2006 Jul;176(1):91-5. doi: 10.1016/S0022-5347(06)00494-0. J Urol. 2006. PMID: 16753376 Clinical Trial.

7

Prostate-specific antigen doubling time is associated with survival in men with hormone-refractory prostate cancer.

Semeniuk RC, Venner PM, North S. Semeniuk RC, et al. Urology. 2006 Sep;68(3):565-9. doi: 10.1016/j.urology.2006.03.055. Urology. 2006. PMID: 17010728

8

The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.

Marwaha S, Venner PM, North SA. Marwaha S, et al. Among authors: venner pm. Can J Urol. 2007 Oct;14(5):3692-6. Can J Urol. 2007. PMID: 17949524

9

A prospective study of the determinants of exercise in bladder cancer survivors using the Theory of Planned Behavior.

Karvinen KH, Courneya KS, Plotnikoff RC, Spence JC, Venner PM, North S. Karvinen KH, et al. Support Care Cancer. 2009 Feb;17(2):171-9. doi: 10.1007/s00520-008-0471-8. Epub 2008 Jun 6. Support Care Cancer. 2009. PMID: 18535848

10

Exercise programming and counseling preferences in bladder cancer survivors: a population-based study.

Karvinen KH, Courneya KS, Venner P, North S. Karvinen KH, et al. Among authors: venner p. J Cancer Surviv. 2007 Mar;1(1):27-34. doi: 10.1007/s11764-007-0010-5. J Cancer Surviv. 2007. PMID: 18648942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters